Safety, Regulation, and Quality Concerns From a regulatory perspective, AOD 9604 is not approved by the US FDA, and thus it has no approved medical indications
However, the viscous semi-solid formulations may cause nasal obstruction during IN administration and reduce the nasal cavitys formulation spreadability [31]
If well tolerated with no concerns, consider either maintaining 0.1 mg once daily or increasing to 0.125 mg once daily based on response
Package and Presintation was perfect Im not as tired but I still have food cravings
This depends on their B12 level and treatment needs
Oral sermorelin should be shelf-stable as long as its kept away from extreme temperatures, but ask your doctor about proper storage procedures to be sure